Deal Tracker · Years

Emerging-market pharma deals in 2021

2 pharma deals announced in 2021 across Africa, tracked by EPT — licensing & localization. Most active: Bio-Thera Solutions, Hikma Pharmaceuticals, Sinovac Biotech & VACSERA. Latest: Bio-Thera Solutions → Hikma Pharmaceuticals (Licensing, 27 Aug 2021).

2
deals tracked
3
countries involved
—
values undisclosed
50%
licensing, the top deal type
  • EPT has tracked 2 emerging-market pharma deals in 2021.
  • The most common structures are licensing (50%) & localization (50%).
  • The countries that appear most often are China (2), Egypt (1) & United States (1).
  • None of these deals disclosed a value, which is common for licensing and distribution agreements in these markets.

Countries involved

China (2) · Egypt (1) · United States (1)

Questions

How many emerging-market pharma deals in 2021 has EPT tracked?
2 as of 27 Aug 2021. The most recent is Bio-Thera Solutions → Hikma Pharmaceuticals (Licensing, 27 Aug 2021).
What types of emerging-market pharma deals in 2021 are most common?
Licensing: 1 (50%); Technology transfer / Localization: 1 (50%).
Which countries appear most in emerging-market pharma deals in 2021?
China (2), Egypt (1), United States (1) — counting where the parties are based and the markets the deals cover.

Browse deals

By region

GCC (83) · MENA (66) · Africa (17) · Latin America (17) · Southeast Asia (17) · Global (LMICs) (14) · CIS & Central Asia (13) · Türkiye (5) · Global ex-US (1)

By country

Saudi Arabia (69) · UAE (61) · China (31) · Egypt (27) · United States (26) · Oman (20) · India (19) · Switzerland (18) · Jordan (14) · South Korea (14) · Kazakhstan (13) · Algeria (12) · Türkiye (12) · United Kingdom (11) · Brazil (10) · Kuwait (10) · Iraq (8) · Morocco (8) · Bahrain (7) · Malaysia (7) · Spain (7) · Argentina (6) · Germany (6) · Indonesia (6) · Philippines (6) · Qatar (6) · Italy (5) · Mexico (5) · Vietnam (5) · France (4) · Taiwan (4) · Tunisia (4) · Canada (3) · Chile (3) · Denmark (3) · Greece (3) · Japan (3) · Lebanon (3) · Nigeria (3) · Pakistan (3) · South Africa (3) · Sweden (3) · Thailand (3) · Azerbaijan (2) · Colombia (2) · Ireland (2) · Kenya (2) · Libya (2) · Netherlands (2) · Singapore (2) · Uruguay (2) · Uzbekistan (2)

By year

2026 (193) · 2025 (27) · 2024 (6) · 2022 (3)

By therapeutic area

Multi-therapy (64) · Oncology (30) · Metabolic / Diabetes (27) · Cardiovascular (17) · Vaccines (15) · Immunology / Inflammation (13) · Rare / Orphan (9) · Infectious Disease (8) · CNS / Neurology (6) · Ophthalmology (6) · Consumer health (5) · Women's Health (4) · Respiratory (2)